Company Continues to Expand Intellectual Property Portfolio Supporting Advanced Placental Allograft Innovation POMPANO BEACH, ...

While Study 1 demonstrated a statistically significant reduction in knee OA pain with ReNu, Study 2 failed to meet its primary efficacy endpoint despite a numerical trend favoring the active treatment ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced ...

Advances progress towards planned Nasdaq uplistingPOMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative ...

BioStem Technologies (BSEM) said on Wednesday the U.S. Patent and Trademark Office issued four U.S. design patents covering its proprietary fenestrated human placental allograft technologies. The ...

Bone grafts treat traumatic injuries and help rejuvenate aging joints. Autografts use tissue from a person’s own body, while allografts use tissue from another person’s body. The different types of ...

Recurrent glomerulonephritis is a known cause of renal allograft loss; however, the incidence of this complication is poorly defined. We determined the incidence, timing, and relative importance of ...

We previously described restrictive allograft syndrome as a form of chronic lung allograft dysfunction, demonstrating restrictive pulmonary function decline. However, the histopathological correlates ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent MPFL reconstruction with autograft or allograft had similar complication rates. However, ...